Insecticide-Treated Baby Wraps for the Prevention of Malaria
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age2-99
SponsorUniversity of North Carolina, Chapel Hill
About this trial
The objective is to test the protective effect of permethrin-treated and etofenprox-treated lesus against malaria in young children
Eligibility criteria
Qualifiers
Mother is at least 18 years old
Mother has access to a working phone with a known number
Mother is the parent or legal guardian of a singleton (i.e., not a twin) infant 2-4 months of age
Has the ability to travel to a designated study site for visits and evaluation
Disqualifiers
Participation in another study of malaria prevention
Known allergic reaction to permethrin or etofenprox
Infant has a known HIV diagnosis (or exposure) or sickle cell disease that would be an indication for malaria prophylaxis
Trial design
Treatments tested in this trial
- Permethrin-treated lesu
- Etofenprox-treated lesu
- Untreated lesu
Treatment groups
1,296 Participants
are divided into 3 treatment groupsSponsors and collaborators
University of North Carolina, Chapel Hill
Lead sponsor
North Carolina State University
Collaborator
Mbarara University of Science and Technology
Collaborator
Source ClinicalTrials.gov